Technology
AI helps Pathologists at Rajiv Gandhi Cancer Institute and Research Center decrease the TAT for Cancer diagnosis
Problem Statement
Rajiv Gandhi Cancer Institute and Research Center (RGCIRC), a project of Indraprastha Cancer Society and Research Centre, a not-for-profit public society, is a medical facility and research institute based in Delhi, specialising in cancer treatment and research. It is one of the largest medical centers for cancer treatment in Asia. RGCIRC uses front-line technology that helps accurate identification of each patient’s unique cancer and planning of treatment for the best possible results. It is the first hospital in India to begin robotic surgery for cancer patients, the first hospital to install a true beam for precision radiotherapy and the first hospital to set up a molecular laboratory.
There is a critical shortage of pathologists, which is more pronounced in India. Cancer diagnosis being complex, takes 2-3 weeks for the test results. Even a routine test requires counting of individual cells and taking the ratio of positive (brown) to negative (blue) stained cells.
Although widely touted as a replacement for glass slides and microscopes in pathology, digital slides present major challenges in interoperability, data storage, security, transmission and processing. In the absence of a standardised data format, each vendor defines its own proprietary data formats, analysis tools, viewers and software libraries. This creates issues for interoperability.
Background
Digitization can help in automating repetitive & mundane tasks, thereby reducing the TAT of the pathologist to provide the correct diagnosis. Other advantages with the digitized workflow include the possibility for more active production planning, allowing staff and managers to keep track of how many specimens are there in the system and where in the production chain they are, whether time limits are being kept, etc. Digitized images also eliminate the need to go to the glass archive when looking for a previously prepared slide. In addition, while glass slides can be broken or lost, a digital image can easily be stored and transmitted.
Digitising images unlocks immense collaborative possibilities, as results can be reviewed by other specialists or research institutions in real time, worldwide, improving the time to diagnosis and prognosis. Combining this with AI solutions – facilitates even faster, and more accurate and consistent clinical decisions.
Healthcare Innovation Challenge (HIC), a flagship initiative of MeitY-NASSCOM Center of Excellence – IoT & AI, is aimed at enabling the Digital Transformation of Healthcare. Lying at the convergence of Healthcare, Technology and Impact creation, HIC is focused on increasing operational efficiency, reducing TAT & associated costs and enhancing patient engagement for Healthcare Providers through the adoption of curated Digital Technology solutions. HIC has a unique Use Case focused framework allowing comprehensive evaluation of Digital solutions through Jury Panels comprising Healthcare, Technology & Regulatory experts, to mitigate the risks associated with digital technology adoption. RGCIRC needed a solution that could help reduce the burden on their histopathologists, reduce the TAT for test results and improve the accuracy of diagnosis and therefore RGCIRC nominated this use case under HIC.
Solution Deployed
Qritive AI India Pvt Ltd, led by Dr Aneesh Sathe and Dr Rajasa Jiasaldani, the HIC winner, has an AI-based solution called Pantheon which is a CE marked vendor-agnostic digital pathology platform that enables digitization of the entire pathology lab workflow. It automates the analysis of Whole Slide Scanner images. It produces a rich diagnostic report and has the capabilities for workflow automation and telepathology. Pantheon has the following capabilities:
- Computer Vision highlights problem areas and auto-detects visual indicators of disease (e.g. counting the total nuclei or classifying tumor tissue)
- Natural Language Processing summarizes patient history for quick reading and analysis
- Vendor agnostic whole slide image management system compatible with Hamamatsu, Philips, Leica, Huron and Morphle
- Integration with major LIS, EMR and other hospital information systems as well as compatible with PACS systems and DICOM protocol
- Data encryption & secure communication protocols
Qritive Pantheon
It has AI modules for Lymphoma, Prostate Cancer, Gastric Cancer, Colon Cancer, Breast Cancer and Alpha-thalassemia. The AI modules have 95% sensitivity and specificity based on 5,00,000 test images and 7000 hours of expert annotation.
Impact
Today, it takes weeks for a cancer patient to get lab results. Qritive AI’s solution reduces the TAT from a week to a day to produce a report for Prostate Cancer and improves accuracy of diagnosis. Pathologist has to largely focus on verifying the report generated by Pantheon.
Prostate Cancer
Mr J P Dwivedi, CIO, RGCIRC said, “Qritive has enabled our pathology to move towards becoming truly Digital. The tissue images captured onsite go to the cloud storage instantly. These images could be studied anywhere and anytime. Hospitals and labs are full of archives of slides. Just as the films have disappeared from Radiology, we envision the same for these slides in pathology. We have already established a tissue bank where tissues will remain stored. At the next level, these slides will all become digital. The next problem was storing, retrieving and sharing these digital slides. The solution took them all to the cloud where our pathologists can upload these images and share those as desired. The prostate Cancer Module powered by AI is helping to create a template for PDSS (Pathologist Decision Support System) and will segregate benign cases with a high degree of confidence straight saving a lot of time for pathologists. With data being available in real time, several opportunities for advanced analytics are opening up.
CoE has truly been instrumental in bringing several solutions including this one to our notice. Healthcare Innovation Challenges (HICs) are doing a remarkable job of bridging the gap of supply and demand of cutting-edge innovative technologies together.”
Dr Gurudutt Gupta, Senior Consultant & Head – Histopathology, RGCIRC said, “This solution has greatly helped us in collaborating with experts where we can seamlessly share the Whole Size Images (WSI) without any inconvenience and with speed. The AI component associated with the solution is going to assist us in increasing throughput and speed of reporting.”
Mr Sanjeev Malhotra, CEO, Center of Excellence – IoT & AI said, “At CoE, we’re aiming to create an impact by leveraging technology to solve real-world challenges. Supported by MeitY, this initiative has been able to create a collaborative innovation ecosystem consisting of deep-tech startups, Med-Tech Enterprises, Pharma companies and Healthcare providers. Our programs follow a unique use-case focussed framework to drive the digital transformation of the healthcare and life sciences sector. We are immensely proud that Rajiv Gandhi Cancer Institute and Research Center have prioritised the adoption of AI-based pathology workflow automation solution to significantly optimise their histopathology analysis”
Mr Sudhanshu Mittal, Head & Director Technical Solutions, CoE Gurugram said, “The role of AI is growing in all dimensions by reducing the role on human operator, thereby allowing the human operator to focus energies in what is really important. The deployments such as the ones at RGCIRC are the real-life demonstrations of the capabilities of AI especially in a sector as sensitive as healthcare. There are multiple other pilots in pipeline where we expect to demonstrate the capabilities of digital technology in solving long pending problems in different sectors”.
Technology
Chery Reaches 15 Millionth Vehicle Milestone: TIGGO 8 Proudly Rolls Off the Line at Brazil’s Manufacturing Base
Recently, Chery Group reached a monumental moment in its journey. In four countries—Egypt, Brazil, Kazakhstan, and Malaysia—Chery vehicles rolled off production lines simultaneously. At the same time, a celebration was held at the Wuhu manufacturing base in China to commemorate the milestone of the 15 millionth vehicle. This series of remarkable achievements signifies Chery’s leap across five continents and weaves together an extraordinary 15-million vehicle roll-off event that transcends borders.
At the 15-million vehicle roll-off ceremony, Yin Tongyue, Chairman of Chery Group, remarked: “From 1 to 15 million, it is not just a growth in product quantity or a breakthrough in Chery’s speed, but an unyielding innovation to turn the impossible into the possible and to turn the possible into even greater possibilities.” Looking ahead to the next 15 million, Chery will focus on the user, build on technology, and take globalization as the direction, striving not only for sales growth but also for advancements in quality, structural optimization, and brand value, bringing global users more delightful, diverse, and differentiated brand options.
TIGGO 8 Shines Globally, Adding Brilliance to the 15 Millionth Vehicle Milestone Celebration
During the global synchronized roll-off ceremony, the TIGGO 8 rolled off the production line at Chery’s Brazil manufacturing base, becoming an integral part of the 15-million milestone achievement. In terms of sales, the TIGGO 8 series has achieved over 1 million global sales, gaining recognition from urban elites worldwide. Additionally, various models of the TIGGO 8 series continue to sell well and gain widespread trust in markets such as Brazil, South Africa, Saudi Arabia, and Ecuador. Since its debut in Brazil in 2020, the TIGGO 8 has received high praise, winning recognition from authoritative institutions and the favor of consumers. It maintains strong sales momentum in Brazil and has become an official reception vehicle for the Brazilian president and a key government procurement vehicle.
With globally recognized quality and performance, the TIGGO 8 series has also won multiple awards, including South Africa’s “2023 Motor Enthusiasts Choice” award, Mexico’s “Top Midsize SUV” and the Philippines’ “Best Midsize Crossover in 19th Annual C!” award.
Global Sales: From 0 to 15 Million, Chery’s Momentum Accelerates
On December 18th, 1999, Chery’s first vehicle rolled off the line. From 0 to 15 million, Chery has maintained its position as China’s top passenger car exporter for 21 consecutive years, expanding its business to over 100 countries and regions. From January to September 2024, Chery Group sold 1,752,793 units, representing a 39.9% year-over-year increase, 93% of its total sales for 2023. Of this, exports reached 829,353 units, marking a 24.5% year-over-year increase, making Chery the only automotive company to achieve dual growth in domestic and overseas markets. As of now, Chery has amassed 15 million global users.
Chery has adhered to a “dual-track” approach in both domestic and international markets, achieving dual growth, with exports accounting for nearly 50% of total sales, showcasing its competitiveness in the global arena. At the same time, Chery has demonstrated strong growth momentum in ICE and NEV. Fuel vehicle sales saw a year-on-year increase of 24.9%, Meanwhile, new energy models have surged with a staggering year-on-year growth rate of 186%.
Global Products: Cars That Meet the Needs of World Users
With its global presence, high-standard R&D, stringent quality control, and excellent product performance, Chery has become a truly global car manufacturer that meets the diverse needs of users worldwide. Chery has established eight major R&D centers and over 300+ laboratories globally, bringing together more than 25,000 top R&D experts to form a strong “scientific elite team” dedicated to solving the mobility needs of new-era users.
From global product planning, design, and development to supply chain management, production, marketing, service, and quality system establishment, Chery adheres to a unified system and quality management standard, ensuring synchronized quality upgrades across global products. Through rigorous testing in extreme conditions worldwide, such as the steep slopes of South America in Brazil, the high humidity and heavy rain of Indonesia, the extreme heat of the Middle East, the autobahns of Germany, and China’s vast geographic span, Chery vehicles have demonstrated their exceptional adaptability and reliability.
The Chery TIGGO series has been a standout in global markets, with the TIGGO series being named the “2023 Global Sales Champion for Chinese Brand Fuel SUVs.” Furthermore, the TIGGO 7 has held the title of the top export champion in the Chinese brand A-segment SUV category for three consecutive years. Many of Chery’s celebrated models, tested by global standards, were showcased at the Global Innovation Day event, including the TIGGO 8 Rally champion car.
Deepening International Cooperation,Co-create a New Future of High-Quality Global Expansion
While rapidly expanding in overseas markets, Chery is also building a high-quality, sustainable “going global” model. Adhering to the international development philosophy of “In somewhere, For somewhere,” Chery collaborates openly with overseas partners to share achievements. With a commitment to being a top performer in global ESG construction and embracing the concept of being a good global corporate citizen, Chery has gained wider recognition and support in overseas markets. The 2024 Chery International User Summit exemplifies Chery’s international influence. The launch of exciting events like Global Innovation Conference(CGIC), International User Summit, Ecology Exhibition and ESG Global Community allows guests worldwide to deeply appreciate Chery’s outstanding achievements and firm determination in technology innovation, environmental construction, and public welfare. These events showcase Chery’s latest technological achievements and cutting-edge ecological concepts and highlight its responsibility and leadership as a global corporate citizen.
In the face of this magnificent milestone, Chery Group celebrates the rollout of its 15 millionth vehicle and embarks on a new chapter in its globalization development. Behind these impressive numbers lies the crystallization of Chery’s 27 years of relentless effort and the testimony of trust and support from 15 million global users. Looking to the future, Chery will continue to deepen international cooperation and produce more global vehicles that meet users’ needs worldwide.
Company: Chery Automobile Co., Ltd.
Contact Person: Chery Automobile
Email: cherybrand@mychery.com
Website: https://www.cheryinternational.com/
Country: China
City: AnHui
Technology
ProX PC: Revolutionizing AI with Cutting-Edge Computing Hardware Solutions for India’s Growing Technology Needs
Technology
The Hub by infinite-VARIABLE Achieves NVidia GeForce Certification, Elevating Gaming and Community Experiences
-
Entertainment3 years agoSmall-town girl Anjali Kumari’s hottest Bollywood song “Katra Katra Again” compared to Mallika Sherawat’s
-
Education1 year agoFostering Sustainability: Highlights and Insights from ICSE 2023
-
Business2 years agoSattva Utilizing the Power of WhatsApp to Communicate Effectively
-
Business2 years agoGreat Place To Work Recognizes LoginRadius as One of India’s Best Workplaces